Comment on: Control of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae using a computer-assisted management program to restrict third-generation cephalosporin use.
Huttner
Benedikt
B
Pittet
Didier
D
Harbarth
Stephan
S
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D019090:Case Management; D002511:Cephalosporins / Q000627:therapeutic use*; D006801:Humans; D007710:Klebsiella Infections / Q000188:drug therapy* / Q000382:microbiology; D007711:Klebsiella pneumoniae / Q000187:drug effects* / Q000201:enzymology; D007723:Korea; D012984:Software; D018440:beta-Lactam Resistance; D001618:beta-Lactamases / Q000096:biosynthesis*
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D001618:beta-Lactamases